Compare SBS & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBS | LH |
|---|---|---|
| Founded | 1954 | 1971 |
| Country | Brazil | United States |
| Employees | N/A | 70000 |
| Industry | Water Supply | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 22.6B |
| IPO Year | 2002 | 2005 |
| Metric | SBS | LH |
|---|---|---|
| Price | $35.21 | $275.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.2M | 507.5K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.29% | 1.07% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 10.46 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | N/A | $8.26 |
| Revenue Next Year | $16.85 | $4.81 |
| P/E Ratio | ★ $15.19 | $25.66 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $18.88 | $218.76 |
| 52 Week High | $35.43 | $293.72 |
| Indicator | SBS | LH |
|---|---|---|
| Relative Strength Index (RSI) | 74.59 | 57.43 |
| Support Level | $23.76 | $259.60 |
| Resistance Level | N/A | $281.62 |
| Average True Range (ATR) | 0.67 | 6.66 |
| MACD | 0.32 | 0.77 |
| Stochastic Oscillator | 97.77 | 88.85 |
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in Sao Paulo State, and supplies treated water and sewage services on a wholesale basis. SABESP may perform activities in other states and countries and can operate in drainage, urban cleaning, solid waste handling, and energy markets. The company determined that it has a single operating segment, which is the provision of sanitation services.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.